Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemiaTommaso Balestra, Sarah K. Tasian|Leukemia|2024Cited by 5